#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Colorectal cancer

Not yet recruiting

Registered drugNo placebo

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Colorectal cancer

Not yet recruiting

Registered drugNo placebo

Study on Electrochemotherapy with Bleomycin for Patients with Colorectal Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bleomycin

Contact Research Centre

Colorectal cancer+1

Not yet recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Nivolumab and Ipilimumab for Patients with Metastatic Colorectal Cancer with dMMR or MSI

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Colorectal cancer+6

Not yet recruiting

InvestigationalNo placebo

Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Colorectal cancer

Not yet recruiting

Registered drug

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Colorectal cancer+2

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Colorectal cancer+4

Not yet recruiting

InvestigationalNo placebo

Study of INCB099280 and Adagrasib for Adults with Advanced Solid Tumors with KRASG12C Mutation

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Colorectal cancer+1

Not yet recruiting

Registered drugNo placebo

Study on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Colorectal cancer

Not recruiting

Registered drugNo placebo

A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Colorectal cancer+1

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of GSK4418959 and Dostarlimab for Adults with Colorectal Cancer with Mismatch Repair Deficiency or High Microsatellite Instability

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Colorectal cancer

Not recruiting

Registered drug

Study on Vitamin D3 and Glycerol for Reducing Fatigue in Colorectal Cancer Patients with Low Vitamin D Levels After Treatment

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Colecalciferol

Contact Research Centre

Colorectal cancer+2

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:AZD0022

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.